Abstract
This paper presents at an instructive level detailed design, decision and computational aspects of p-values and power for clinical trials in which interim looks at accumulating data are planned. Background theory and an application are presented. In addition, a definition of the term p-value, appropriate for a trial in which interim looks are planned is proposed. The definition is intuitively consistent with that for a fixed sample size trial. That is, the p-value reflects the strength of the data against the null hypothesis. For trials incorporating group sequential methods, the p-value at a particular look reflects the conditional nature of the data collected through that look on the data collected through earlier looks.
Original language | American English |
---|---|
Journal | Journal of Chronic Diseases |
Volume | 40 |
DOIs | |
State | Published - 1987 |
Keywords
- Clinical trials
- Conditional partitioning of type I risk
- Group sequential methods
- Interim analyses
- Power
- PowerClinical trials
- p-Value
DC Disciplines
- Public Health
- Biostatistics